STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[Form 4] Sharps Technology Inc. Warrant Insider Trading Activity

Filing Impact
(Moderate)
Filing Sentiment
(Positive)
Form Type
4
Rhea-AI Filing Summary

Timothy James Ruemler, a director of Sharps Technology Inc., reported multiple dispositions of Common Stock on 08/25/2025 at prices ranging from $9.60 to $12.50, after which he beneficially owns 40,218 shares. The Form 4 also discloses a grant of an option under the company's 2025 Equity Incentive Plan dated 08/22/2025 to purchase 80,000 shares at an exercise price of $6.41. The option will become 100% vested and exercisable on May 22, 2026, and the option covers 80,000 underlying common shares.

Positive
  • Director retains beneficial ownership of 40,218 common shares after reported transactions
  • Received an 80,000-share option under the 2025 Equity Incentive Plan with a $6.41 exercise price
  • Option vests 100% and becomes exercisable on May 22, 2026, aligning incentives to future performance
Negative
  • Multiple dispositions on 08/25/2025 indicate the insider sold portions of his common stock holdings
  • Significant reduction in immediate common-stock exposure compared with prior holdings (final reported 40,218 shares)

Insights

TL;DR: Director sold multiple tranches of common stock and received a large option grant that vests in 2026, altering near-term equity exposure.

The reported activity shows significant disposals of common shares on a single date, reducing direct common stock holdings to 40,218 shares. Concurrently, the director received an 80,000-share option at a $6.41 strike under the 2025 Equity Incentive Plan that becomes fully exercisable on May 22, 2026. For investors, the combination of cashing out some equity while receiving long-dated, low-strike options is a meaningful change in the insider's compensation and risk profile; it increases potential future upside exposure while realizing present value from share sales. This filing is material to ownership and incentive alignment but does not provide company operating results.

TL;DR: Insider transactions include staged share disposals and a time‑vesting option grant under the company's equity plan.

The Form 4 documents disciplined use of the 2025 Equity Incentive Plan: a grant of an option for 80,000 shares with explicit vesting on May 22, 2026, and multiple open-market or plan-related dispositions on 08/25/2025 leaving the director with 40,218 shares. From a governance perspective, the grant and vesting schedule align the director's incentives to future performance over the next year. The filing is a routine but material disclosure regarding insider compensation and ownership structure.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Ruemler Timothy James

(Last) (First) (Middle)
C/O SHARPS TECHNOLOGY, INC.
105 MAXESS ROAD, STE. 124

(Street)
MELVILLE NY 11747

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Sharps Technology Inc. [ STSS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
08/22/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/25/2025 P 5,000 D $12.48 5,218 D
Common Stock 08/25/2025 P 5,000 D $11.84 10,218 D
Common Stock 08/25/2025 P 5,000 D $12 15,218 D
Common Stock 08/25/2025 P 5,000 D $12.5 20,218 D
Common Stock 08/25/2025 P 5,000 D $11.22 25,218 D
Common Stock 08/25/2025 P 5,000 D $10.6335 30,218 D
Common Stock 08/25/2025 P 5,000 D $10.5 35,218 D
Common Stock 08/25/2025 P 4,682 D $9.69 39,900 D
Common Stock 08/25/2025 P 118 D $9.63 40,018 D
Common Stock 08/25/2025 P 100 D $9.6 40,118 D
Common Stock 08/25/2025 P 100 D $9.69 40,218 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Option (right to buy) $6.41 08/22/2025 P 80,000 (1) 08/22/2035 Common Stock 80,000 $6.41 80,000 D
Explanation of Responses:
1. Granted pursuant to the Company's 2025 Equity Incentive Plan. The option will become 100% vested and exercisable on May 22, 2026.
/s/ Timothy Ruemler 08/26/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions were reported for Sharps Technology (STSS/STSSW)?

The filing shows multiple dispositions of Common Stock on 08/25/2025 leaving the reporting person with 40,218 shares, and a grant of an option for 80,000 shares at $6.41 dated 08/22/2025.

How many shares does the reporting person beneficially own after the transactions?

The reporting person beneficially owns 40,218 common shares following the reported transactions.

What are the terms of the option grant disclosed on the Form 4?

The option covers 80,000 common shares with an exercise price of $6.41, granted under the 2025 Equity Incentive Plan and will be 100% vested and exercisable on May 22, 2026.

On what date were the common stock dispositions executed?

All reported common stock disposals occurred on 08/25/2025 at prices between $9.60 and $12.50.

Is the option exercisable immediately?

No. The Form 4 explanation states the option will become 100% vested and exercisable on May 22, 2026.
Sharps Technology Inc

NASDAQ:STSSW

STSSW Rankings

STSSW Latest News

STSSW Latest SEC Filings

STSSW Stock Data

8.81M
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States
MELVILLE